Abstract
Like many countries, India has opted to protect new plant varieties through a sui generis legislation aimed at protecting new plant varieties. Given the increased use of biotechnology to create genetically modified plants and the fact that these inventions can be protected under patent law, there is the question of overlaps of both legal regimes. These issues of overlap are not new since jurisdictions like the EU have previously witnessed significant litigation on this issue and subsequently incorporated certain safeguards in the EU Biotech Directive to reduce the confusion arising from overlaps between its patent law and its law on plant variety protection. This article will analyse the issues raised in India and propose a framework to resolve the overlaps.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
